Trifluridine/Tipiracil and ATR-CHK1-WEE1 pathway inhibition against TP53-mutant esophageal cancer as synthetic lethality

被引：0
|
作者：
Kikuchi, Osamu [1 ,2 ]
Trang Nguyen [1 ,3 ]
Ohashi, Shinya [3 ,4 ]
Muto, Manabu [2 ,3 ]
机构：
[1] Kyoto Univ, Ctr Canc Immunotherapy & Immunobiol, Kyoto, Japan
[2] Kyoto Univ, Clin Bioresource Ctr, Kyoto, Japan
[3] Kyoto Univ, Med Oncol, Kyoto, Japan
[4] Kyoto Univ, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3003
引用
收藏
页码：1342 / 1342
页数：1
相关论文
共 50 条
  • [1] Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer
    Gorecki, Lukas
    Andrs, Martin
    Korabecny, Jan
    CANCERS, 2021, 13 (04) : 1 - 23
  • [2] Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma
    Vu, Trang H. Nguyen
    Kikuchi, Osamu
    Ohashi, Shinya
    Saito, Tomoki
    Ida, Tomomi
    Nakai, Yukie
    Cao, Yang
    Yamamoto, Yoshihiro
    Kondo, Yuki
    Mitani, Yosuke
    Kataoka, Shigeki
    Kondo, Tomohiro
    Katada, Chikatoshi
    Yamada, Atsushi
    Matsubara, Junichi
    Muto, Manabu
    CANCER SCIENCE, 2023, 114 (12) : 4664 - 4676
  • [3] ATR-CHK1-WEE1 pathway is a critical dependency in the context of DNA damage and replicative stress in osteosarcoma
    Sayles, Leanne C.
    Martell, Henry
    Koehne, Amanda
    Ang, Kean-Hooi
    Wilson, Chris
    Arkin, Michelle
    Sweet-Cordero, E. Alejandro
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [4] Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma
    Ohashi, Shinya
    Kikuchi, Osamu
    Nakai, Yukie
    Ida, Tomomi
    Saito, Tomoki
    Kondo, Yuki
    Yamamoto, Yoshihiro
    Mitani, Yosuke
    Nguyen Vu, Trang H.
    Fukuyama, Keita
    Tsukihara, Hiroshi
    Suzuki, Norihiko
    Muto, Manabu
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (06) : 1363 - 1372
  • [5] Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers
    Patterson-Fortin, Jeffrey
    Bose, Arindam
    Tsai, Wei-Chih
    Grochala, Carter
    Nguyen, Huy
    Zhou, Jia
    Parmar, Kalindi
    Lazaro, Jean-Bernard
    Liu, Joyce
    McQueen, Kelsey
    Shapiro, Geoffrey I.
    Kozono, David
    D'Andrea, Alan D.
    CANCER RESEARCH, 2022, 82 (20) : 3815 - 3829
  • [6] ATR-Chk1-Wee1 pathway controls melanoma cell cycle in G2-M and G0-G1
    Vera, J.
    Raatz, Y.
    Kottek, T.
    Bhattacharya, A.
    Simon, J. C.
    Kunz, M.
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (03) : E33 - E33
  • [7] Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
    Sanjiv, Kumar
    Hagenkort, Anna
    Calderon-Montano, Jose Manuel
    Koolmeister, Tobias
    Reaper, Philip M.
    Mortusewicz, Oliver
    Jacques, Sylvain A.
    Kuiper, Raoul V.
    Schultz, Niklas
    Scobie, Martin
    Charlton, Peter A.
    Pollard, John R.
    Berglund, Ulrika Warpman
    Altun, Mikael
    Helleday, Thomas
    CELL REPORTS, 2016, 14 (02): : 298 - 309
  • [8] ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
    Smith, Hannah L.
    Willmore, Elaine
    Prendergast, Lisa
    Curtin, Nicola J.
    BRITISH JOURNAL OF CANCER, 2024, 131 (05) : 905 - 917
  • [9] Wee1 inhibition and its synthetic lethal combination with Chk1 inhibition in mouse model of neuroendocrine prostate cancer
    Chao, Yapeng
    Chen, Yuzhou
    Liu, Yu
    Connelly, Jaclyn A.
    Wang, Hong
    Wang, Qiming Jane
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer
    Yapeng Chao
    Yuzhou Chen
    Wenxiao Zheng
    Kathryn Demanelis
    Yu Liu
    Jaclyn A. Connelly
    Hong Wang
    Song Li
    Qiming Jane Wang
    Oncogene, 2024, 43 : 789 - 803
12345